Comprehensive magnetic resonance of peripheral arterial disease
Phase of Trial: Phase III
Latest Information Update: 23 Aug 2017
At a glance
- Drugs Ezetimibe (Primary) ; Ezetimibe/simvastatin (Primary) ; Simvastatin (Primary)
- Indications Atherosclerosis; Peripheral arterial disorders
- Focus Therapeutic Use
- 02 Feb 2012 Actual patient number changed from 67 to 85 as reported by ClinicalTrials.gov.
- 02 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Oct 2011 Actual patient numbers changed to 67 as reported in Atherosclerosis.